Informations générales (source: ClinicalTrials.gov)
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
Observational
ANRS, Emerging Infectious Diseases (Voir sur ClinicalTrials)
septembre 2021
juin 2023
29 juin 2024
This is a prospective, multicentric, non comparative study aiming to evaluate the
clinical and virological evolution of high-risk patients infected with SARS-CoV-2 treated
withtin the framework of a cohort ATU ('Autorisation temporaire d'utilisation') or
authorisation for early access (AAP) delivered by the French drug agency (ANSM).
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| AP-HP - Hôpital Avicenne | Olivier Bouchaud | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Bichat | Nathan Peiffer-Smadjat | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Cochin | Benjamin Terrier | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Necker-Enfants Malades | Fanny Lanternnier | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Saint Antoine | Karine Lacombe | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Tenon | Gilles Pialloux | Contact (sur clinicalTrials) | |||
| CENTRE HOSPITALIER SUD FRANCILIEN | Pierre Housset | Contact (sur clinicalTrials) | |||
| CHI POISSY ST-GERMAIN | Mathilde Devaux | Contact (sur clinicalTrials) | |||
| CTRE EXAMENS SANTE CORBEIL ESSONNES | Anne-Marie Ronchetti | Contact (sur clinicalTrials) | |||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CHR Metz-Thionville - Ars-Laquenexy - France | Jérome Frey | Contact (sur clinicalTrials) | |||
| CHU d'Angers - Angers - France | Vincent Dubée | Contact (sur clinicalTrials) | |||
| CHU de Rennes - Rennes - France | Audrey Le Bot | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CH Agen-Nerac - Agen - France | Albert Trinh-Duc | Contact (sur clinicalTrials) | |||
| CH de Tarbes - Tarbes - France | Philippe Petua | Contact (sur clinicalTrials) | |||
| CH de Tourcoing - Tourcoing - France | Olivier Robineau | Contact (sur clinicalTrials) | |||
| CHRU de Nancy - 54511 - Nancy - France | Benjamin Lefèvre | Contact (sur clinicalTrials) | |||
| CHRU de Tours - Hôpital Bretonneau - Tours - France | François Coustilleres | Contact (sur clinicalTrials) | |||
| CHU de Bordeaux - 33076 - Bordeaux - France | Charles Cazanave | Contact (sur clinicalTrials) | |||
| CHU de Dijon - Dijon - France | Lionel Piroth | Contact (sur clinicalTrials) | |||
| CHU de Limoges - Limoges - France | Jean-François Faucher | Contact (sur clinicalTrials) | |||
| CHU de Martinique - 97261 - Fort-de-France - France | André Cabié | Contact (sur clinicalTrials) | |||
| CHU de Montpellier - Montpellier - France | Alain Makinson | Contact (sur clinicalTrials) | |||
| CHU de Nantes - Nantes - France | François Raffi | Contact (sur clinicalTrials) | |||
| CHU de Nîmes - Nîmes - France | Aurélie Martin | Contact (sur clinicalTrials) | |||
| CHU de Poitiers - Poitiers - France | Jean-Philippe Martellosio | Contact (sur clinicalTrials) | |||
| CHU de Toulouse - IUCT - Oncopole - Toulouse - France | Aurore Perrot | Contact (sur clinicalTrials) | |||
| CHU de Toulouse - Toulouse - France | Guillaume Martin-Blondel | Contact (sur clinicalTrials) | |||
| CHU Gabriel Montpied - Clermont-Ferrand - France | Natacha Mrozek | Contact (sur clinicalTrials) | |||
| Hôpital Bicêtre - Médecine interne - 94275 - Le Kremlin-Bicêtre - France | Cécile Goujard | Contact (sur clinicalTrials) | |||
| Hôpital Bicêtre - SMIT - 94275 - Le Kremlin-Bicêtre - France | Stéphane Jauréguiberry | Contact (sur clinicalTrials) | |||
| Hôpital Lariboisière - SAU SMUR - Paris - France | Anthony Chauvin | Contact (sur clinicalTrials) | |||
| Hôpital Lariboisière - SMIT - 75010 - Paris - France | Véronique Delcey | Contact (sur clinicalTrials) | |||
| Hôpital Pitié-Salpêtrière - Paris - France | Valérie Pourcher | Contact (sur clinicalTrials) | |||
| Hôpital Saint-Louis - Paris - France | Nathalie De Castro | Contact (sur clinicalTrials) | |||
| Hospices Civils de Lyon (HCL) - Lyon - France | Florence Ader | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Adults with the criteria for COVID-19 treatment within the French compassionate
program (ATU/AAP)
- Adults covered by the French social health coverage
- Adults who signed the informed consent form
- Adults with the criteria for COVID-19 treatment within the French compassionate
program (ATU/AAP)
- Adults covered by the French social health coverage
- Adults who signed the informed consent form
- Exclusion criteria described in the French compassionate program (ATU/AAP)
- Patient participating in another biomedical research with an exclusion period
ongoing at inclusion
- Vulnerable patient (adults legally protected: under judicial protection,
guardianship, or supervision, persons deprived of their liberty)
- Pregnant or breastfeeding woman